Latest Updates on VRTX
-
Biotechnology This "Orphan Drug" Biotech Could Double in Less Than Three Years
The three biggest Big Pharma "blockbuster" medicines of all time target high cholesterol (Lipitor), inflammatory diseases (Humira), and digestive afflictions (Nexium) and have pulled in a combined $350 billion - and counting. But what about … Read more » -
Biotechnology How to Cash In on the Biggest Medical Breakthrough of the Decade
Imagine if all it took to treat a case of cancer was taking out the trash. Now, I want you to imagine that your body could do it all for you. Hold that thought. Because a tech platform with that very task in mind is set to hit the … Read more » -
Biotechnology Get Your Hands on the World's First $1 Billion Cannabis Drug
When it comes to biotech, Wall Street tends to overreact. Though there's no reason for it to be there, biotech is in the dog house, and investors have been conditioned to punish the sector and its stocks whenever the opportunity presents itself. … Read more » -
Stocks The Secret Formula That Makes Biotech Investing Profitable
Everyone knows that you can make a lot of money investing in biotech stocks. However, you also risk losing all your hard-earned money. Read more » -
Stocks Top Stocks to Watch Today: DEPO, VRTX, EXAR
The top three stocks to watch today are DEPO, VRTX, and EXAR. Brexit has officially begun in the midst of the largest growth in global trade of goods in seven years. Read more »
